UNDINE

bioMérieux is a world leader in the field of microbiology, a specialist in immunoassays and molecular syndromic diagnostics. The Company employs nearly 13,000 people worldwide, is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. Within bioMérieux R&D, the global goal of the Open Innovation & Partnerships Department, in which Dr. Aurore Fleurie (PI in UNDINE) is involved as Sr Manager R&D, is to validate clinically meaningful and medically relevant host and pathogen biomarkers having medical and financial impact on patients, healthcare systems and society as a whole. Within UNDINE, bMx will optimize the detection of neutralizing type I IFN autoantibodies as a part of work package 5.